Skip to main content

Table 2 CD133 expression in relation to clinical and pathological parameters in a series of 137 colon cancers

From: Increased expression of CD133 and reduced dystroglycan expression are strong predictors of poor outcome in colon cancer patients

  Total Low High p value
   n (%) n (%)  
Gender
Males 78 41 (53) 37 (47)  
Females 59 31 (52) 28 (48) n.s.
Age (yr)
≤68 73 35 (48) 38 (52)  
>68 64 37 (58) 27 (42) n.s.
Tumor Grading
1 9 4 (44) 5 (56)  
2 86 50 (58) 36 (42)  
3 42 18 (43) 24 (57) n.s.
pT parameter
pT1 12 3 (25) 9 (75)  
pT2 17 7 (41) 10 (59)  
pT3 75 48 (64) 27 (36)  
pT4 33 14 ( 42) 19 (58) 0.02
Nodal status
Negative 76 42 (55) 34 (45)  
Positive 61 30 (49) 31 (51) n.s.
Tumor stage
I 25 9 (36) 16 (64)  
II 43 31 (72) 12 (28)  
III 69 32 (46) 37 (54) 0.006
Recurrence
YES 57 22 (39) 35 (61)  
NOT 80 50 (62) 30 (37) 0.005
Follow-up
Deceased 51 20 (39) 31 (61)  
Alive 86 52 (61) 34 (39) 0.013
α-DG staining
Low 68 28 (41) 40 (59)  
High 69 44 (64) 25 (36) 0.006
  1. n.s.: not significant.